Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005

Mark D Reller1, Matthew J Strickland, Tiffany Riehle-Colarusso

  • 1Oregon Health and Science University, Portland, OR, USA.

Insights

Congenital heart defects (CHD) affect approximately 81.4 per 10,000 births, with common types including ventricular and atrial septal defects. This study provides current prevalence estimates for various CHD subtypes.

Area of Science:

  • Cardiology
  • Pediatrics
  • Public Health

Background:

  • Congenital heart defects (CHD) represent a significant global health concern.
  • Accurate prevalence data is crucial for resource allocation and understanding disease burden.

Purpose of the Study:

  • To establish precise prevalence rates for congenital heart defects (CHD) utilizing contemporary diagnostic methods.
  • To identify the most frequent subtypes of CHD and their demographic associations.

Main Methods:

  • Data was sourced from the Metropolitan Atlanta Congenital Defects Program (MACDP) surveillance system.
  • Infants born between 1998 and 2005 with CHD were identified, excluding physiologic shunts.
  • Infant and maternal characteristics were compared with the general birth cohort.

Main Results:

  • An overall CHD prevalence of 81.4 per 10,000 births was observed from 398,140 births (1998-2005).
  • Muscular ventricular septal defect (27.5/10,000), perimembranous ventricular septal defect (10.6/10,000), and secundum atrial septal defect (10.3/10,000) were most common.
  • Tetralogy of Fallot (4.7/10,000) was the most prevalent cyanotic CHD, followed by transposition of the great arteries (2.3/10,000).
  • Associations were noted between common CHD, advanced maternal age, multiple gestations, and sex.

Conclusions:

  • This research offers updated prevalence figures for diverse CHD subtypes based on standardized classification.
  • These findings are valuable for analyzing geographic, temporal, and demographic variations in CHD occurrence.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...